DICHAMA Trademark

Trademark Overview

On Tuesday, February 7, 2023, a trademark application was filed for DICHAMA with the United States Patent and Trademark Office. The USPTO has given the DICHAMA trademark a serial number of 97784259. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, September 19, 2025. This trademark is owned by Insmed Incorporated. The DICHAMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of sarcoidosis, interstitial lung disease, pulmonary fibrosis, and idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment of pulmonary hypertension, pulmonary arterial hypertension (PAH), pulmonary hypertension associated with lung disease, pulmonary hypertension associated with interstitial lung disease (PH-ILD), pulmonary hypertension associated with chronic obstructive pulmonary disease, portopulmonary hypertension, pulmonary hypertension associated with sleep-related breathing disorders, pulmonary hypertension associated with chronic thrombotic and embolic disease, and pulmonary hypertension secondary to hematologic, metabolic, renal, granulomatous, or fibrotic disorders
dichama

General Information

Serial Number97784259
Word MarkDICHAMA
Filing DateTuesday, February 7, 2023
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, September 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of sarcoidosis, interstitial lung disease, pulmonary fibrosis, and idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment of pulmonary hypertension, pulmonary arterial hypertension (PAH), pulmonary hypertension associated with lung disease, pulmonary hypertension associated with interstitial lung disease (PH-ILD), pulmonary hypertension associated with chronic obstructive pulmonary disease, portopulmonary hypertension, pulmonary hypertension associated with sleep-related breathing disorders, pulmonary hypertension associated with chronic thrombotic and embolic disease, and pulmonary hypertension secondary to hematologic, metabolic, renal, granulomatous, or fibrotic disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, February 26, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInsmed Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807
Party NameInsmed Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Friday, February 10, 2023NEW APPLICATION ENTERED
Sunday, February 26, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 30, 2023ASSIGNED TO EXAMINER
Friday, September 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 17, 2024SOU EXTENSION 1 FILED
Wednesday, January 17, 2024SOU EXTENSION 1 GRANTED
Friday, January 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 18, 2025SOU TEAS EXTENSION RECEIVED
Monday, September 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2024SOU EXTENSION 2 GRANTED
Monday, September 16, 2024SOU EXTENSION 2 FILED
Tuesday, February 18, 2025SOU EXTENSION 3 FILED
Wednesday, February 19, 2025SOU EXTENSION 3 GRANTED
Wednesday, February 19, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 10, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 10, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 10, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 10, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, September 9, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 9, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 9, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 9, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 19, 2025SOU EXTENSION 4 FILED
Friday, September 19, 2025SOU TEAS EXTENSION RECEIVED
Friday, September 19, 2025SOU EXTENSION 4 GRANTED
Saturday, September 20, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 9, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

dichama pulmonary hypertension disease associated lung disorders pharmaceutical fibrosis chronic treatment